Medanta Cardiometabolic Disease Study




  • Jubilant Life Sciences


  • Medanta

End Date:

  • Ongoing

Medanta Cardiometabolic Disease Study

We are conducting a prospective study of coronary artery disease and type II diabetes mellitus, to identify novel metabolic markers that discriminate these diseases in an Indian population. Clinical data and biological specimen collection will take place in the cardiac catheterization lab and outpatient clinics at Medanta Hospital and in rural cardiovascular outreach camps. Peripheral blood molecular biomarker profiling will occur at Duke.